Post-christmas COVID thoughts from dark Northumberland. TL;DR Omicron is rising across the world, and hospitalisations are following, but it seems clear Omicron-COVID is different from previous variants; the actions needed to steer a safe path in Omicron Europe are still murky
Context: I am an expert in human genetics and computational biology. I know expets in infectious epidemiology, viral genomics, immunology and clinical trials. I have some conflicts of interest; I am consultant and shareholder of Oxford Nanopore and was on the Ox/Az trial.
Brief recap; SARS-CoV-2 is a new human coronavirus which jumped from an animal host in late 2019. It causes a horrible disease, COVID, which often leads to death in a subset of people (older, more likely to be male and obesse) and can triggers a CFS-like disease, LongCOVID.
Over 2020 and most of 2021 societies reacted to this threat first by significantly dampening transmission of the virus and then by vaccines which were created in record time. Clinicians rapidly improved how they handled the disease, aided by large, fast clinical trials.
In late 2021 the first "endemic" variant appeared, Omicron, rapidly characterised by excellent work from South Africa. It had enough differences to evade immune systems educated either by previous non-Omicron infection or by 2-doses of vaccine.
(This "drift the major spike antigen" to prevent neutralising host immunity is how Coronaviruses roll; the 4 endemic human coronaviruses all do this, and its well documented in coronavirus infection patterns. So this is all expected if very concerning and complex to sort out)
Omicron is both immune evading (like Beta and Gamma before it) and fast transmitting (like Alpha and Delta), a potent combination which led to doubling rates of every 2 to 3 days; 10-fold in a week, 100-fold in 2 weeks. Case charts leap up as Omicron hits a country.
Thankfully good data linkage and tracking in England and Scotland both confirmed the immune evasion properties of Omicron and that 3-doses ("boosters") provided neutralising immunity to infection - hence the importance of booster and vaccination campaigns.
South Africa had relatively low hospitalisations and deaths compared to previous waves, suggesting that Omicron on top of previous infection at least was not as severe; this was confirmed by English+Scottish data showing less severity (in particular in double or triple vax)
Furthermore there is consistent reports of different biology (less ICU and Oxygen needs, different location of viral replication being more throat and less lung and nose) - all points to a different viral infection biology as well as immunity differences.
However, this shift in biology and less severity - extremely welcome - doesn't wipe out the risks as all healthcare serivces almost certainly cannot handle everyone who could get sick from this getting sick in the same 2 weeks.
The complications of the holiday season in Europe and America has made it even more complex to manage; Politicians responding to broad societal wishes of family celebrations have held off changes either post Christmas (eg Wales, Scotland, Germany) or beyond (England, France, US).
Holidays has also changed mixing patterns ( intergenerational), testing behaviour (far more deployment and use of rapid tests) + reporting. As such it is extremely hard to use current stats over these two weeks to know what is happening, though hospitalisations are most reliable.
(If there is a pundit on this site or other location who talk with confidence about the trajectory of any country from this week I would be very skeptical of claims).
As such countries have set the course this week; in something like 10 days from now we will be settling into new "exit from Omicron wave" schemes. Worth noting that South Africa has pretty much got through Omicron (at least my reading from SA epidemiology twitter).
What does an exit from Omicron need? We still don't know how much of Omicron's low severity extends to immunologically naive people, though the fast rising hospitalisations in US suggests not (though sorting out Delta from Omicron is still complex).
Clearly the safest position is to have as many people vaccinated (3-doses, first dose the most important). It seems unlikely one can easily prevent exposure as Omicron moves through the population, so unexposed, vaccine hestitant people are the biggest risk.
Here there is often I think too much focus on aggregate country numbers (78% vaccinated) and not enough on age-stratified vaccination numbers; more complex, harder to aggregate, sometimes not easily available (eg, Germany) and harder to explain, but the most important variable.
Omicron's infectiousness over 2-vax, previous also means there is a new workforce issue of isolation - important to really be on top of for healthcare workers. This greatly complicates navigating Omicron.
But we also have new weapons - eg anti-viral drugs (note a UK scheme to have pre-positioned test-at-home for vulnerable people with express couriered anti-virals to home to try to stop hospitalisations) and in-home monitoring for low risk discharge (oxygen meters)
Faster, immune evading Omicron infection but with less inherent severity and new clinical approaches means we have multiple variables moving around at the same time; even more complexity for analysts and ultimately decision makers.
It is tempting just to go slow - lockdown to get time to see perhaps mistakes or successes other countries make - and yet lockdowns themselves cause harm (we've not been collectively good at measuring them) and some things we desparately don't want to lockdown, notably schools.
Just as UK agonised in mid-december about how much one could extrapolate from South Africa on severity (somewhat it turns out, but it's complex), other European countries are going to agonise about how much they can extrapolate/understand from UK and DK, the early Omicron leaders
(France though looks like it is catching up with UK and DK quickly, in particular in Paris / Ile-de-France, and if Omicron takes off in PACA I guess we will understand even better Omicron severity in unvaccinated individuals).
No matter the course taken I think though it will go fast, because Omicron's infection rate is so fast. Hold tight, take care, and look after yourself, your family and your friends because Omicron is coming to everyone, quickly.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Ewan Birney

Ewan Birney Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ewanbirney

23 Dec
COVID thoughts from beautiful, misty Northumberland. TL;DR As expected, Omicron is exploding in numbers in cities and beyond worldwide. Reassuringly Omicron infections are less likely to end up in hospital, but whether this reduction in severity is enough to be safe is unclear
Context: I am an expert in human genetics and computational biology. I know experts in infectious epidemiology, viral genomics, immunology and clinical trials. I have some conflicts of interest: I am a consultant and sharehold of Oxford Nanopore and I was on the Ox/Az trial.
Reminder: Omicron is the first "antigen drift" variant with fast transmission from SARS-CoV-2. This drifting antigen presentation on spike is one of the ways Coronaviruses shift their appearance to our immune system, so it was expected, though always not fully appreciated.
Read 32 tweets
22 Dec
With Scottish, English and South African data all in hospitalisation risk given infection all coming in below 50% (range I think 80% lower SA to 60% lower, English some endpoints) this key parameter is firming up. Frustratingly in the balance from my reading of the SPI-M models
(plus "what does xx% lower mean - xx% per infection or per equivalent infection knowing that Omicron reinfects etc," and how does one factor this vs vaccination and age - so much detail here to nail down)
Basically, good news, and provides narrower spaces for models (both forward models and backward models on infection levels as hospitalisations are more completely ascertained than cases etc).
Read 4 tweets
22 Dec
In general I am impressed and v. positive about how the UK Science community does analysis and feeds into UK Government - SAGE and tip-of-the-spear Patrick Vallance. eg, It's notable how Germany's new expert modelling/academic group under the new Government has a nod to this.
(UK is a very mixed bag in pandemic response. Some is knock it out of the park good - RECOVERY trial, some has improved hugely over a year - data flows, testing, sequencing, and some is ... really not so good. That's a British understatement for non-Brits).
...but...
Read 5 tweets
18 Dec
Omicron thoughts from dark, Christmas London. TL;DR - Europe+World is facing the Omicron storm and it looks increasingly bad; and, obviously, the virus doesn't care about Christmas. Despite some serious response in the UK, this virus is replicating fast; more action likely needed
Context: I am an expert in human genetics and computational biology. I know experts in infectious epidemiology, viral genomics, immunology and clinical trials. I have some COIs: I am consultant and shareholder of ONT and was on the Ox/Az trial.
Reminder: SARS-CoV-2 is a recently jumped coronavirus into humans which causes a very nasty disease, COVID, in a subset of people. It has rushed across the world over 2 years, combatted by lockdowns and more recently vaccines, but causing death and disease in many places.
Read 25 tweets
17 Dec
One consistent thing in this pandemic is for a given virus biology (parameters of infection, immune escape, disease severity) the growth or reduction fits models / understanding well
(A short diversion here between forecast/now cast models - accurately predicting the next handful of days - and scenario models - helping decision makers plan given uncertain parameters and choices for intervention-
Forecast models absolutely should be benchmarked to outturn. Scenario models for the discovered parameters and interventions benchmarked by shape and size but less so timing)
Read 8 tweets
11 Dec
COVID thoughts from cold, Christmas London. TL;DR The Omicron storm clouds are glowering above Europe, but its unclear whether this will just be rain and hail of COVID or rain, hail, tornados and hurricanes of infection and subsequent hospitalisation of COVID.
Context: I am an expert in human genetics and computational biology. I know experts in infectious epidemiology, viral genomics, immunology, public health and clinical trials. I have COIs - I am consultant and shareholder to Oxford Nanopore and was on the Ox/Az vaccine trial.
Reminder: COVID is horrible disease triggered by the infection of SARS-CoV-2 in a subset of people. A combination of reducing contacts (early), reducing travel (some countries) and vaccination brought SARS-CoV-2 towards a somewhat endemic trajectory over 2020 and 2021. However >>
Read 25 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(